Victory Capital Management Inc. Increases Position in UnitedHealth Group (UNH)

Victory Capital Management Inc. increased its position in UnitedHealth Group (NYSE:UNH) by 9.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 309,014 shares of the healthcare conglomerate’s stock after purchasing an additional 27,442 shares during the quarter. Victory Capital Management Inc.’s holdings in UnitedHealth Group were worth $66,129,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Ninepoint Partners LP bought a new position in UnitedHealth Group during the third quarter worth about $24,546,000. Sowell Financial Services LLC boosted its holdings in UnitedHealth Group by 31.8% during the third quarter. Sowell Financial Services LLC now owns 7,087 shares of the healthcare conglomerate’s stock worth $1,485,000 after buying an additional 1,710 shares during the last quarter. Ameriprise Financial Inc. boosted its holdings in UnitedHealth Group by 9.4% during the third quarter. Ameriprise Financial Inc. now owns 3,532,500 shares of the healthcare conglomerate’s stock worth $691,952,000 after buying an additional 302,996 shares during the last quarter. Pictet & Cie Europe SA boosted its holdings in UnitedHealth Group by 3.8% during the third quarter. Pictet & Cie Europe SA now owns 22,654 shares of the healthcare conglomerate’s stock worth $4,437,000 after buying an additional 833 shares during the last quarter. Finally, Spectrum Management Group Inc. boosted its holdings in UnitedHealth Group by 9.1% during the third quarter. Spectrum Management Group Inc. now owns 3,017 shares of the healthcare conglomerate’s stock worth $591,000 after buying an additional 252 shares during the last quarter. Hedge funds and other institutional investors own 87.11% of the company’s stock.

A number of equities analysts have issued reports on the company. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, March 28th. Credit Suisse Group reiterated a “buy” rating on shares of UnitedHealth Group in a report on Friday, March 9th. ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday, May 2nd. JPMorgan Chase lifted their price objective on UnitedHealth Group to $266.00 and gave the company an “overweight” rating in a report on Wednesday, April 18th. Finally, Oppenheimer lifted their price objective on UnitedHealth Group from $260.00 to $276.00 and gave the company an “outperform” rating in a report on Wednesday, April 18th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $253.70.

In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, March 19th. The stock was sold at an average price of $224.36, for a total transaction of $2,243,600.00. Following the transaction, the director now owns 1,771,257 shares of the company’s stock, valued at approximately $397,399,220.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, April 23rd. The stock was sold at an average price of $234.20, for a total value of $3,513,000.00. Following the transaction, the director now directly owns 1,761,533 shares in the company, valued at approximately $412,551,028.60. The disclosure for this sale can be found here. Insiders sold a total of 72,019 shares of company stock worth $16,550,733 in the last 90 days. Company insiders own 0.87% of the company’s stock.

UnitedHealth Group opened at $242.96 on Friday, according to MarketBeat. The company has a market capitalization of $232.29 billion, a price-to-earnings ratio of 24.13, a PEG ratio of 1.39 and a beta of 0.75. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.56. UnitedHealth Group has a 52 week low of $238.61 and a 52 week high of $240.48.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.91 by $0.13. The firm had revenue of $55.19 billion for the quarter, compared to analysts’ expectations of $54.90 billion. UnitedHealth Group had a return on equity of 22.06% and a net margin of 5.41%. The business’s quarterly revenue was up 13.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.37 EPS. equities analysts expect that UnitedHealth Group will post 12.61 EPS for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply